Big strokes in small persons

Archives of Neurology

Volumn 64, Issue 11, 2007, Pages 1567-1574

  Adams, Robert J ^a,b,c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON CHELATING AGENT;

ARTERY EMBOLISM; BLOOD FLOW; BLOOD TRANSFUSION; BRAIN ANGIOGRAPHY; BRAIN CIRCULUS ARTERIOSUS; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; GENOTYPE; HIGH RISK PATIENT; HUMAN; INTERNAL CAROTID ARTERY; IRON OVERLOAD; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE CEREBRAL ARTERY; PRIORITY JOURNAL; RETICULOCYTE; REVIEW; RISK FACTOR; SICKLE CELL ANEMIA; STROKE;

ANEMIA, SICKLE CELL; CEREBROVASCULAR CIRCULATION; HUMANS; MODELS, BIOLOGICAL; PEDIATRICS; RISK; STROKE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 36148945980     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.11.1567     Document Type: Review

References (38)

1. Herrick JB. Peculiar elongated and sickle-shaped red corpuscles in a case of severe anemia. Arch Intern Med. 1910;6:517-521.
2. Pauling L, Itano HA, Singer SJ, Wells IC. Sickle cell anemia: a molecular disease. Science. 1949;110(2865):543-548.
3. Syndenstricker VP, Mulherin WA, Houseal RW. Sickle cell anemia. AJDC. 1923; 26:132-154.
4. Bridgers WA. Cerebral vascular disease accompanying sickle cell anemia. Am J Pathol. 1939;15:353-362.
5. Steinberg MH, Brugnara C. Pathophysiological-based approaches to treatment of sickle cell disease. Annu Rev Med. 2003;54:89-112.
6. Baird RL, Weiss DL, Ferguson AD, French JH, Scott RB. Studies in sickle cell anemia: clinical-pathological aspects of neurological manifestations. Pediatrics. 1964;34:92-100.
7. Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med. 1997; 337(11):762-769.
8. Turhan A, Weiss LA, Mohandas N, Coller BS, Frenette PS. Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proc Natl Acad Sci U S A. 2002;99(5):3047-3051.
9. Platt OS. Preventing stroke in sickle cell anemia. N Engl J Med. 2005;353(26):2743-2745.
10. Stockman JA, Nigro MA, Mishkin MM, Oski FA. Occlusion of large cerebral vessels in sickle-cell anemia. N Engl J Med. 1972;287(17):846-849.
11. Adams RJ, Nichols FT. Sickle cell anemia, sickle cell trait and thalassemia. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Vascular Diseases: Part III. Amsterdam, the Netherlands: Elsevier Science Publications; 1989:503-515. Handbook of Clinical Neurology ; vol 11.
12. Russell MO, Goldberg HI, Hodson A, et al. Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood. 1984;63(1):162-169.
13. Aaslid R, Markwalder TM, Nornes H. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg. 1982; 57(6):769-774.
14. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91(1):288-294.
15. Adams RJ, Nichols FT, Figueroa R, McKie VC, Lott T. Transcranial Doppler correlation with cerebral angiography in sickle cell disease. Stroke. 1992;23(8):1073-1077.
16. Adams RJ, McKie VC, Carl EM, et al. Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol. 1997;42(5):699-704.
17. Broderick J, Talbot GT, Prenger E, Leach A, Brott T. Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol. 1993;8(3):250-255.
18. Miller ST, Macklin EA, Pegelow CH, et al; Cooperative Study of Sickle Cell Disease. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr. 2001;139(3):385-390.
19. Pegelow CH, Adams RJ, McKie VC, et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr. 1995;126(6):896-899.
20. Goldstein LB, Adams RJ, Becker K, et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 2001;32(1):280-299.
21. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339(1):5-11.
22. el Gammal T, Adams RJ, Nichols FT, et al. MR and CT investigation of cerebrovascular disease in sickle cell patients. AJNR Am J Neuroradiol. 1986;7(6):1043-1049.
23. Pavlakis SG, Bello J, Prohovnik I, et al. Brain infarction in sickle cell anemia: magnetic resonance imaging correlates. Ann Neurol. 1988;23(2):125-130.
24. Brass LM, Pavlakis SG, DeVivo D, et al. Transcranial Doppler measurements of the middle cerebral artery: effect of hematocrit. Stroke. 1988;19(12):1466-1469.
25. Adams RJ, Nichols FT, McKie VC, et al. Transcranial Doppler: influence of hematocrit in children with sickle cell anemia without stroke. J Cardiovasc Ultrasonogr. 1989;8(2):97-101.
26. Adams RJ, Nichols FT, Stephens S, et al. Transcranial Doppler: the influence of age and hematocrit in normal children. J Cardiovasc Ultrasonogr. 1988;7(3):201-205.
27. Adams R, McKie VC, Nichols FT, et al. The use of transcranial ultrasonography to predict stroke in sickle-cell disease. N Engl J Med. 1992;326(9):605-610.
28. Adams RJ, McKie VC, Brambilla DJ, et al. Stroke prevention trial in sickle cell anemia. Control Clin Trials. 1998;19(1):110-129.
29. Zimmerman RA. MRI/MRA evaluation of sickle cell disease of the brain. Pediatr Radiol. 2005;35(3):249-257.
30. Abboud MR, Cure J, Granger S, et al. Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study. Blood. 2004;103(7):2822-2826.
31. National Heart, Lung, and Blood Institute. Clinical alert: periodic transfusions lower stroke risk in children with sickle cell anemia. http://www.nlm.nih.gov/databases/alerts/sickle97.html. Accessed August 29, 2007.
32. Adams RJ, Brambilla D; Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators. Discontinuing prophylactic transfusions to prevent stroke in sickle cell disease. N Engl J Med. 2005;353(26):2769-2778.
33. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293(13):1653-1662.
34. Fullerton HJ, Johnston SC, Zhao S, Adams RJ. Declining rates in Californian children with sickle cell disease. Blood. 2004;104(2):336-339.
35. Adams RJ, Pavlakis S, Roach ES. Sickle cell disease and stroke: primary prevention and transcranial Doppler. Ann Neurol. 2003;54(5):559-563.
36. Lee MT, Piomelli S, Granger S, et al. Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results. Blood. 2006;108(3):847-852.
37. ClinicalTrials.gov Web site. Silent Cerebral Infarct Multi-Center Clinical Trial. http://www.clinicaltrials.gov/ct/show/NCT00072761. Accessed August 29, 2007.
38. ClinicalTrials.gov Web site. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH). http://www.clinicaltrials.gov/ct/show/NCT00122980. Accessed August 29, 2007.